Liquid pharmaceutical composition for nasal administration conta

Details Liquid pharmaceutical composition for nasal administration conta Liquid pharmaceutical composition for nasal administration conta

1991-06-17

1992-06-23

Doll, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514530, 514307, 514 3, 514 4, 514 15, 514800, 514808, 424719, A61K 3702

Patent

active

051243156

ABSTRACT:
A liquid composition for nasal administration of polypeptide/s containing ammonium tartrate and a buffer together with optional adiuvants.

REFERENCES:
patent: Re32919 (1989-05-01), Sarnoff
patent: 4466960 (1984-08-01), Silverman et al.
patent: 4476116 (1988-10-01), Anik
patent: 4772585 (1988-09-01), Sarnoff et al.
patent: 4900730 (1990-02-01), Miyalechi
patent: 4985242 (1991-01-01), Sekine et al.
patent: 5010056 (1991-04-01), Boghen et al.
patent: 5015626 (1991-05-01), Christian et al.
patent: 5015627 (1991-05-01), Lindsey et al.
patent: 5026546 (1991-06-01), Hilgers et al.

Affiliated with

Also associated with

Rating

Liquid pharmaceutical composition for nasal administration conta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid pharmaceutical composition for nasal administration conta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid pharmaceutical composition for nasal administration conta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-932894